Citation: Alena V Malakhova, Olga I Rudko, Vladimir V Sobolev, Artemii V Tretiakov, Elena A Naumova, Zarema G Kokaeva, Julia E Azimova, Eugene A Klimov. PDE4B gene polymorphism in Russian patients with panic disorder[J]. AIMS Genetics, 2019, 6(3): 55-63. doi: 10.3934/genet.2019.3.55
[1] | Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158: 1568–1578. doi: 10.1176/appi.ajp.158.10.1568 |
[2] | Jeong Kim E, Kim YK (2018) Panic disorders: The role of genetics and epigenetics. AIMS Genet 5: 177–190. doi: 10.3934/genet.2018.3.177 |
[3] | O'Donnell JM, Frith S (1999) Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases. Pharmacol Biochem Behav 63: 185–192. doi: 10.1016/S0091-3057(98)00267-6 |
[4] | Davis RL, Cherry J, Dauwalder B, et al. (1995) The cyclic AMP system and Drosophila learning. Mol Cell Biochem 149–150: 271–278. |
[5] | Millar JK, Pickard BS, Mackie S, et al. (2005) DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310: 1187–1191. doi: 10.1126/science.1112915 |
[6] | Pickard BS, Thomson PA, Christoforou A, et al. (2007) The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 17: 129–133. doi: 10.1097/YPG.0b013e328014492b |
[7] | Fatemi SH, King DP, Reutiman TJ, et al. (2008) PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr Res 101: 36–49. doi: 10.1016/j.schres.2008.01.029 |
[8] | Numata S, Ueno S, Iga J, et al. (2008) Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population. J Psychiatr Res 43: 7–12. doi: 10.1016/j.jpsychires.2008.01.013 |
[9] | Kahler AK, Otnaess MK, Wirgenes KV, et al. (2010) Association study of PDE4B gene variants in Scandinavian schizophrenia and bipolar disorder multicenter case-control samples. Am J Med Genet B Neuropsychiatr Genet 153B: 86–96. |
[10] | Numata S, Iga J, Nakataki M, et al. (2009) Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 150B: 527–534. doi: 10.1002/ajmg.b.30852 |
[11] | Millar JK, Mackie S, Clapcote SJ, et al. (2007) Disrupted in schizophrenia 1 and phosphodiesterase 4B: Towards an understanding of psychiatric illness. J Physiol 584: 401–405. doi: 10.1113/jphysiol.2007.140210 |
[12] | Tropea D, Hardingham N, Millar K, et al. (2018) Mechanisms underlying the role of DISC1 in synaptic plasticity. J Physiol 596: 2747–2771. doi: 10.1113/JP274330 |
[13] | Cherry JA, Davis RL (1999) Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect. J Comp Neurol 407: 287–301. doi: 10.1002/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R |
[14] | Charney DS, Deutch A (1996) A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 10: 419–446. doi: 10.1615/CritRevNeurobiol.v10.i3-4.70 |
[15] | Pandey SC, Zhang H, Roy A, et al. (2005) Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest 115: 2762–2773. doi: 10.1172/JCI24381 |
[16] | Li YF, Huang Y, Amsdell SL, et al. (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34: 2404–2419. doi: 10.1038/npp.2009.66 |
[17] | Silvestre JS, Fernandez AG, Palacios JM (1999) Effects of rolipram on the elevated plus-maze test in rats: A preliminary study. J Psychopharmacol 13: 274–277. doi: 10.1177/026988119901300309 |
[18] | Rutter AR, Poffe A, Cavallini P, et al. (2014) GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species. J Pharmacol Exp Ther 350: 153–163. doi: 10.1124/jpet.114.214155 |
[19] | Malberg JE, Eisch AJ, Nestler EJ, et al. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104–9110. doi: 10.1523/JNEUROSCI.20-24-09104.2000 |
[20] | Dlaboga D, Hajjhussein H, O'Donnell JM (2006) Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram. Brain Res 1096: 104–112. doi: 10.1016/j.brainres.2006.04.032 |
[21] | Cherry JA, Thompson BE, Pho V (2001) Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse. Biochim Biophys Acta 1518: 27–35. doi: 10.1016/S0167-4781(01)00164-6 |
[22] | Zhang HT, Huang Y, Masood A, et al. (2008) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology 33: 1611–1623. doi: 10.1038/sj.npp.1301537 |
[23] | Otowa T, Kawamura Y, Sugaya N, et al. (2011) Association study of PDE4B with panic disorder in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatry 35: 545–549. doi: 10.1016/j.pnpbp.2010.12.013 |
[24] | Feng Y, Cheng D, Zhang C, et al. (2016) Association of PDE4B Polymorphisms with Susceptibility to Schizophrenia: A Meta-Analysis of Case-Control Studies. PLoS One 11: e0147092. doi: 10.1371/journal.pone.0147092 |
[25] | Abramson JH (2011) WINPEPI updated: Computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8: 1. doi: 10.1186/1742-5573-8-1 |
[26] | Favorov AV, Andreewski TV, Sudomoina MA, et al. (2005) A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans. Genetics 171: 2113–2121. doi: 10.1534/genetics.105.048090 |
[27] | Desmet FO, Hamroun D, Lalande M, et al. (2009) Human Splicing Finder: An online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37: e67. doi: 10.1093/nar/gkp215 |
[28] | Clarke TK, Adams MJ, Davies G, et al. (2017) Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N = 112, 117). Mol Psychiatry 22: 1376–1384. doi: 10.1038/mp.2017.153 |
[29] | Meshberg-Cohen S, Svikis D (2007) Panic disorder, trait anxiety, and alcohol use in pregnant and nonpregnant women. Compr Psychiatry 48: 504–510. doi: 10.1016/j.comppsych.2007.06.004 |
[30] | Marquez M, Segui J, Canet J, et al. (2003) Alcoholism in 274 patients with panic disorder in Spain, one of the main producers of wine worldwide. J Affect Disord 75: 237–245. doi: 10.1016/S0165-0327(02)00054-X |
[31] | McNamara D (2006) Panic Attack/Alcohol Use Association Greater in Men. Clinical Psychiatry News 34: 43. |
[32] | Bae JS, Park BL, Cheong HS, et al. (2015) Association analysis of PDE4B polymorphisms with schizophrenia and smooth pursuit eye movement abnormality in a Korean population. Gen Physiol Biophys 34: 277–284. doi: 10.4149/gpb_2015004 |
[33] | Zhang L, Chen C, He C, et al. (2010) Association study of schizophrenia and phosphodiesterase 4B gene polymorphism. Chin J Behav Med Brain Sci 19: 429–431. |
[34] | Guan F, Zhang C, Wei S, et al. (2012) Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese. Hum Genet 131: 1047–1056. doi: 10.1007/s00439-011-1120-8 |